Pediatric ovarian dysgerminoma with highly elevated serum neuron-specific enolase

Pediatr Int. 2018 Oct;60(10):982-983. doi: 10.1111/ped.13676.

Authors

Tomomi Hayase¹, Daisuke Matsubara², Kosaku Maeda³, Toshinori Aihara⁴, Akira Morimoto¹

Affiliations

¹ Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
² Department of Diagnostic Pathology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
³ Department of Pediatric Surgery, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
⁴ Department of Pediatric Medical Imaging, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.

PMID: 30345703
DOI: 10.1111/ped.13676

No abstract available

Keywords: cancer antigen 125; dysgerminoma; half-life; neuron-specific enolase; tumor marker.

Publication types

Case Reports

MeSH terms

Adolescent
Antineoplastic Agents / therapeutic use
Biomarkers, Tumor / blood
CA-125 Antigen / blood
Dysgerminoma / diagnosis*
Dysgerminoma / drug therapy
Dysgerminoma / surgery
Female
Humans
L-Lactate Dehydrogenase / blood
Ovarian Neoplasms / diagnosis*
Ovarian Neoplasms / drug therapy
Ovarian Neoplasms / surgery
Ovary / pathology
Phosphopyruvate Hydratase / blood*
Salpingo-oophorectomy / methods

Substances

Antineoplastic Agents
Biomarkers, Tumor
CA-125 Antigen
L-Lactate Dehydrogenase
Phosphopyruvate Hydratase